Dr Reddys Laboratories Share Price
Know More₹1,151.25 1.50 (0.13%)
04:01 PM, 3-Apr-2025₹1,151.45 1.45 (0.13%)
03:49 PM, 3-Apr-2025BSE : 500124
NSE : DRREDDY
Sector : Health care
ISIN Code : INE089A01031
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 03-Apr-2025 | 09:31 PM IST
| Market Cap (₹ Cr.) | 96,072 |
Traded Value (₹ Cr) | 21.66 |
Volume (Shares) | 1,88,118 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,420.20 |
52-Week High Date | 21-Aug-2024 |
52-Week Low (₹) | 1,093.00 |
52-Week Low Date | 12-Mar-2025 |
All Time High (₹) | 1,420.20 |
All Time High Date | 21-Aug-2024 |
All Time Low (₹) | 0.77 |
All Time Low Date | 11-Jun-1990 |
Dr Reddys Laboratories Ltd
Dr Reddy's Labs News
Dr Reddy's Labs Announcement
Dr Reddys Laboratories Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Data Not Found | |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Bank of India Multi Asset Allocation Fund-Reg (G) | 4.04 | 36,500 | 1.25 |
| Bank of India Multi Asset Allocation Fund-Reg (IDCW) | 4.04 | 36,500 | 1.25 |
| Bank of India Multi Asset Allocation Fund-Dir (G) | 4.04 | 36,500 | 1.25 |
| Bank of India Multi Asset Allocation Fund-Dir (IDCW) | 4.04 | 36,500 | 1.25 |
| Nippon India Hybrid Bond Fund (G) | 0.74 | 6,635 | 0.09 |
| Nippon India Hybrid Bond Fund - Direct (G) | 0.74 | 6,635 | 0.09 |
| HDFC Retirement Savings Fund-Hybrid Debt (G) | 0.55 | 5,000 | 0.36 |
| HDFC Retirement Savings Fund-Hybrid Debt-Dir (G) | 0.55 | 5,000 | 0.36 |
Research Reports
Stock Strength
| Today's Low/High (₹) | 1,149.05 1,226.90 |
| Week Low/High (₹) | 1,135.00 1,226.90 |
| Month Low/High (₹) | 1,092.45 1,226.90 |
| Year Low/High (₹) | 1,092.45 1,421.00 |
| All time Low/High (₹) | 0.77 1,421.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -0.94% | -0.92% | -1.69% | -1.45% |
| 1 Month | 2.83% | 2.84% | 4.39% | 5.11% |
| 3 Month | -14.88% | -14.87% | -3.70% | -3.14% |
| 6 Month | -14.51% | -14.53% | -7.52% | -7.92% |
| 1 Year | -5.96% | -5.99% | 3.27% | 3.63% |
| 3 Year | 34.56% | 34.53% | 28.71% | 31.58% |
Company Info
Company Information
Co-Chairman & Managing Directo : G V Prasad
Executive Chairman : K Satish Reddy
Independent Director : Shikha Sanjaya Sharma
Lead Independent Director : Leo Puri
Independent Director : K P Krishnan
Independent Director : Pennv Wan
Company Sec. & Compli. Officer : K Randhir Singh
Independent Director : Arun M. Kumar
Independent Director : Claudio Albrecht
Independent Director : Sanjiv Mehta
Independent Director : Alpna Seth
Registered Office: 8-2-337 Road No 3, Banjara Hills,Hyderabad,Telangana-500034 Ph: 91-40-49002900
FAQs about Dr Reddys Laboratories Ltd
1. What's the Dr Reddys Laboratories Ltd share price today?
Dr Reddys Laboratories Ltd share price was Rs 1,151.25 at 04:01 PM IST on 3rd Apr 2025. Dr Reddys Laboratories Ltd share price was up by 0.13% over the previous closing price of Rs 1,149.75. Dr Reddys Laboratories Ltd share price trend:
- Last 1 Month: Dr Reddys Laboratories Ltd share price moved up by 2.83% on BSE
- Last 3 Months: Dr Reddys Laboratories Ltd share price moved down by 14.88% on BSE
- Last 12 Months: Dr Reddys Laboratories Ltd share price moved down by 5.96% on BSE
- Last 3 Years: Dr Reddys Laboratories Ltd price moved up by 34.56% on BSE
2. How can I quickly analyse the performance of the Dr Reddys Laboratories Ltd stock?
The performance of the Dr Reddys Laboratories Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 17.89
- Price to book value ratio is 3.12
- Dividend yield of 0.69
- The EPS (trailing 12 months) of the Dr Reddys Laboratories Ltd stock is Rs 64.37
3. What is the market cap of Dr Reddys Laboratories Ltd?
Dr Reddys Laboratories Ltd has a market capitalisation of Rs 96,072 crore.
4. What is Dr Reddys Laboratories Ltd's 52-week high/low share price?
The Dr Reddys Laboratories Ltd’s 52-week high share price is Rs 1,420.20 and 52-week low share price is Rs 1,093.00.
5. Is the Dr Reddys Laboratories Ltd profitable?
On a consolidated basis, Dr Reddys Laboratories Ltd reported a profit of Rs 849.40 crore on a total income of Rs 5,250.40 crore for the quarter ended 2024. For the year ended Dec 2024, Dr Reddys Laboratories Ltd had posted a profit of Rs 1,404.20 crore on a total income of Rs 8,535.60 crore.
6. Which are Dr Reddys Laboratories Ltd’s peers in the Health care sector?
Dr Reddys Laboratories Ltd’s top 5 peers in the Health care sector are Cipla, Torrent Pharma., Mankind Pharma, Dr Reddy's Labs, Lupin, Zydus Lifesci., Aurobindo Pharma.
7. Who owns how much in Dr Reddys Laboratories Ltd?
Key changes to the Dr Reddys Laboratories Ltd shareholding are as follows:
- Promoter holding in Dr Reddys Laboratories Ltd has gone down to 26.64 per cent as of Dec 2024 from 26.65 per cent as of Mar 2024.
